Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Cardiovasc Hematol Disord Drug Targets 2018;18:139-46.ArticlePubMed REFERENCES PubReader ePub Link Cite this Article Cite this Article Close Download Citation Close XML Download Figure Related articles Sodium-Glucose Cotransporter 2 Inhibitors as Emerging Anticancer Agents New Users of Sodium-Glucose Cotransporter 2 Inhibitors Are at Low Risk of Prostate Cancer: A Nationwide Cohort Study Anti-Senescence Effect of Inhibiting Sodium-Glucose Cotransporter 2 and -Glucosidase in a Type 2 Diabetes Mellitus Animal Model Benefit and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Older Patients with Type 2 Diabetes Mellitus Graphical abstract Graphical abstract Table 1
25.67 Clonal nevus: high-power view of type A nevus cells with fine pigmentation
"Glutathione, oxidative stress and aging." GeroScience
The Role of Compounded Medications: Cost can be a significant barrier to accessing effective treatments
Eliza Burr discussed the effects of GLP-1 and GLP-1/GIP receptor agonists on female sexual function, and in respect to age group in two subsequent studies
US$ 24.05
US$ 29.62
US$ 27.96
